CYP2C19 Loss-of-Function is an Associated Risk Factor for Premature Coronary Artery Disease: A Case–Control Study
International Journal of General Medicine,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 5049 - 5058
Published: Nov. 1, 2024
Objective:
Cytochrome
P450
2C19
(CYP2C19)
is
a
major
enzyme
involved
in
the
biotransformation
and
metabolism
of
various
substances.
Loss-of-function
CYP2C19
gene
represents
downregulation
indication
limited
or
no
enzymatic
function,
which
may
be,
turn,
associated
with
some
disease
susceptibility.
The
relationship
between
polymorphisms
susceptibility
to
premature
coronary
artery
(PCAD)
not
fully
understood.
This
study
aimed
assess
this
relationship.
Methods:
included
635
PCAD
patients,
548
age-matched
non-CAD
individuals
as
controls,
from
November
2019
August
2023.
rs4244285
(681G
>
A,
*2)
rs4986893
(636G
*3)
were
genotyped,
distribution
patients
controls
risk
analyzed.
Results:
A
total
442
(37.4%),
543
(45.9%),
198
(16.7%)
had
extensive
metabolizer
(EM)
(*1/*1),
intermediate
(IM)
(*1/*2
*1/*3),
poor
(PM)
(*2/*2,
*2/*3,
*3/*3)
phenotypes,
respectively.
*2/*2
genotype
frequency
was
higher,
*1/*1
lower
than
controls.
Individuals
PM
phenotype
higher
triglyceride
(TG)
levels
those
EM
IM
phenotypes.
Logistic
regression
analysis
showed
that
body
mass
index
(BMI)
≥
24.0
kg/m
2
(≥
vs
18.5–
23.9
,
odds
ratio
(OR):
1.326,
95%
confidence
interval
(CI):
1.041–
1.688,
p
=
0.022),
smoking
(OR:
1.974,
CI:
1.283–
3.306,
0.002),
hypertension
1.327,
1.044–
1.687,
0.021),
diabetes
mellitus
1.390,
1.054–
1.834,
0.020),
(PM
phenotype,
OR:
1.701,
1.200–
2.411,
0.003),
IM+PM
phenotypes
(IM+PM
1.369,
1.077–
1.740,
0.010)
PCAD.
Conclusion:
overweight,
smoking,
hypertension,
Keywords:
disease,
cytochrome
P450,
CYP2C19,
loss-of-function
Language: Английский
CYP2C19 Poor Metabolizer Status and High System Inflammation Response Index are Independent Risk Factors for Premature Myocardial Infarction: A Hospital-Based Retrospective Study
Wendao Han,
No information about this author
Nating Xiong,
No information about this author
Renkai Zhong
No information about this author
et al.
International Journal of General Medicine,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 4959 - 4969
Published: Oct. 1, 2024
Atherosclerosis
(AS)
is
a
sustained
chronic
vascular
inflammatory
response
caused
by
lipid
metabolism
disorders
and
immune
the
main
cause
of
premature
(men
≤
55
years
old,
women
65
old)
myocardial
infarction
(PMI).
Cytochrome
P450
2C19
(CYP2C19)
(related
to
function
metabolism)
peripheral
cell
levels
plays
an
important
role
in
course
AS.
The
association
Language: Английский
CYP2C19 loss-of-function variants are independent risk factors for premature cerebral infarction: a hospital based retrospective study
Yuliang Shi,
No information about this author
Yuxian Yang,
No information about this author
Miaoling Feng
No information about this author
et al.
BMC Cardiovascular Disorders,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 29, 2024
Abstract
Objective
Cytochrome
P450
2C19
(CYP2C19)
plays
an
vital
role
in
the
course
of
cardiovascular
and
cerebrovascular
diseases
by
affecting
lipid
metabolism.
Triglyceride-glucose
(TyG)
is
a
comprehensive
index
composed
triglyceride
blood
glucose,
has
relationship
with
some
diseases.
There
was
no
research
report
on
association
CYP2C19
polymorphisms,
TyG
premature
cerebral
infarction
(CI)
(onset
≤
65
years
old)
susceptibility.
Methods
This
study
retrospectively
analyzed
1953
CI
patients
aged
old
from
December
2018
to
March
2024,
1919
age-matched
individuals
non-CI
as
controls.
The
between
risk
were
analyzed.
Results
proportion
hypertension,
diabetes
mellitus
higher
than
those
serum
total
cholesterol
(TC),
triglycerides
(TG),
low-density
lipoprotein-cholesterol
(LDL-C),
levels
significantly
controls
(all
p
<
0.05).
had
lower
*1
allele
frequency
(63.3%
vs.
69.6%,
0.001)
*2
(31.3%
25.4%,
Logistic
regression
analysis
showed
that
smoking
history
(odds
ratio
(OR):
1.193,
95%
confidence
interval
(CI):
1.002–1.422,
=
0.048),
hypertension
(OR:
3.371,
CI:
2.914–3.898,
0.001),
1.911,
1.632–2.237,
intermediate
metabolizer
(IM)
+
poor
(PM)
phenotypes
1.424,
1.243–1.631,
dyslipidemia
1.294,
1.077–1.554,
0.006)
independent
factors
for
CI.
Conclusions
History
smoking,
mellitus,
dyslipidemia,
IM
PM
independently
associated
Language: Английский